ZYVERSA THERAPEUTICS, INC.

Insiders ZyVersa Therapeutics, Inc.

Equities

ZVSA

US98987D3008

Market Closed - Nasdaq Other stock markets 16:30:01 2024-05-31 EDT			5-day change	1st Jan Change
4.94 ^USD	+21.08%		+14.62%	-45.11%

05-15	ZyVersa Therapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	CI
03-25	ZyVersa Therapeutics, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	CI

Insiders

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

ZyVersa Therapeutics, Inc. Announces Board Changes	23-08-18	CI
ZyVersa Therapeutics, Inc. Announces Changes to Board of Directors	23-05-19	CI
Zyversa Therapeutics Announces That Richard J. Glassock Has Joined Zyversa’a Renal Scientific Advisory Board	23-03-07	CI
ZyVersa Therapeutics Reports Inducement Grant to Newly Appointed Chief Medical Officer Under Nasdaq Listing Rule 5635(c)(4)	23-01-27	GL
ZyVersa Therapeutics, Inc. Appoints Dr. Pablo Guzman as Chief Medical Officer and Senior Vice President of Medical Affairs	23-01-27	CI
ZyVersa Therapeutics, Inc. Announces Executive Changes	23-01-05	CI
ZyVersa Therapeutics, Inc. Adds Two Esteemed Leaders to Its Renal Scientific Advisory Board	23-01-03	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Discover our Free Content to Help You Better Understand the Stock Market.

100% Free Registration

fermer